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Publication bias occurs when the publication of research results depends not only on the quality
of the research but also on its nature and direction. The consequence is that published studies may
not be truly representative of all valid studies undertaken, and this bias may threaten the validity of
systematic reviews and meta-analyses - on which evidence-based medicine increasingly relies. Mul-
tivariate meta-analysis has recently received increasing attention for its ability reducing potential
bias and improving statistical efficiency by borrowing information across outcomes. However, detect-
ing and accounting for publication bias are more challenging in multivariate meta-analysis setting
because some studies may be completely unpublished whereas some studies may selectively report
part of multiple outcomes. In this paper, we propose a score test for jointly testing publication bias
for multiple outcomes, which is novel to the multivariate setting. The proposed test is a natural
multivariate extension of the univariate Egger’s test, and can handle the above mentioned scenarios
simultaneously, It accounts for correlations among multivariate outcomes, while allowing different
types of outcomes, and can borrow information across outcomes. The proposed test is shown to
be more powerful than the Egger’s test, Begg’s test and Trim and Fill method through simulation
studies. Two data analyses are given to illustrate the performance of the proposed test in practice.
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1 Introduction
The interest in research synthesis and meta-analysis has rapidly grown over the last few decades. From
today’s point of view, it is difficult to think of scientific research without the possibility to integrate
different findings into one big picture. In meta-analysis, publication bias (PB) is a well-known
important and challenging issue may threaten the the validity of the results [1, 2]. PB is defined as
the publication or non-publication of studies depending on the direction, the statistical significance of
the results and other potential information such as language (selective inclusion of studies published
in English), availability (selective inclusion of studies easily accessible to the researcher) and others
[3]. It is important to differentiate PB from the inclusion bias due to the conduct of meta-analysis.
For the latter bias, the criteria for including studies in a meta-analysis is influenced by knowledge of
the results of the set of potential studies [4]. In this paper, we focus only on detecting PB and do
not consider the inclusion bias due to the conduct of meta-analysis.
It may lead to erroneous conclusions being drawn from a meta-analysis if PB is not detected and
adjusted. For example, the conclusions from some meta-analyses were later found to be contradicted
with mega trials [5]. In the last two decades, a great deal of attention has been devoted to developing
statistical methods to detect and correct for PB using the data to be meta-analyzed [3, 6]. Graphic
methods based on funnel plots have been used as the basis to detect PB in meta-analysis. Because the
precision in estimating the underlying treatment effect will increase as the sample size of component
studies increases, results from small studies will scatter widely at the bottom of the funnel graph, with
the spread narrowing among larger studies. A symmetrical inverted funnel indicates the absence of
PB, while asymmetry inverted funnel indicates the potential PB [7, 8]. However, observations based
on funnel plots itself can be subjective. Without quantitatively measured the funnel plot asymmetry,
different observers may have different interpretation of the observations. Statistical tests based on
funnel plot asymmetry have been developed in the literature to assess PB, e.g., the rank correlation
test [9], and regression tests [10, 11, 12, 13, 14]. [15, 16] further developed the “Trim and Fill” method
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for estimating and adjusting for the number of missing studies in meta-analysis. It is based on the
idea that missing studies due to PB implies an asymmetrical funnel. The Trim and Fill method does
not only test for PB, but also offers a correction to the estimates of overall effect size.
Recently, multivariate meta-analysis (MMA) has received a great deal of attention, which jointly
analyzes multiple and possibly correlated outcomes [17]. However, to the best of our knowledge,
the commonly used graphical and statistical methods proposed for univariate outcome are no longer
sufficient. For example, consider a meta-analysis with two primary outcomes. All existing univariate
tests can only detect the PB of each outcome separately. One possible way to apply these tests in
MMA is to define an combined univariate effect measure (e.g., diagnostic odds ratio combining the
information on sensitivity and specificity). [6] reviewed the performance of several statistical tests for
PB in meta-analysis of diagnostic accuracy studies by applying the methods to univariate measures
such as logarithm of diagnostic odds ratio, and concluded that using the Trim and Fill method on
the logarithm of diagnostic odds ratio has non-inflated or slightly inflated Type I errors and medium
to high power. However, the multivariate nature is not fully accounted for and there could be loss
of information due to the reduction to one single measure [6]. More importantly, for general meta-
analysis with multivariate outcomes, the outcomes may be in different scales, e.g., meta-analysis of
drug efficacy and safety studies [18], and it is difficult to define a meaningful combined univariate
effect measure (see section 5.3 for an example). Even if the outcomes are in the same scale, the
interpretation of such a combined measure may be difficult.
In this paper, we propose regression-based test to detect PB in multivariate meta-analysis, which
is a natural multivariate extension of the Egger’s regression test. By jointly modeling on multivariate
outcomes, the proposed test can fully account for the multivariate nature. In addition, by borrowing
information across outcomes, this score test detects PB for both completely missing and partially
missing scenarios simultaneously. Furthermore, the proposed test allows different types of outcomes.
The proposed test approximately follows a simple χ2 distribution, and is robust and powerful com-
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paring to existing univariate methods, suggesting that the proposed test can be used as a default
method for test of PB.
This paper is organized as follows. In Section 2, we introduce the notations for multivariate
random-effects meta-analysis and briefly review the existing methods for univariate meta-analysis
based on funnel plots. In Section 3, we propose the regression-based score test. In Section 4, we
conduct simulation studies to compare the proposed test with existing methods. We illustrate the
proposed method by two real data analyses in Section 5. Finally, we provide a brief discussion in
Section 6.
2 Notations and existing methods
2.1 Notations for bivariate random-effects meta-analysis
To simplify our presentation, we describe the bivariate random-effect model (BRMA) under normal
distribution assumption, acknowledging that the proposed test can be easily extended to the mul-
tivariate setting. We consider a meta-analysis with m studies where two outcomes in each study
are of interest. For the ith study, denote Yij and sij the summary measure for the jth outcome of
interest and associated standard error respectively, both assumed known, i = 1, . . . , m, and j = 1, 2.
Each summary measure Yij is an estimate of the true effect size θij . To account for heterogeneity in
effect size across studies, we assume θij to be independently drawn from a common distribution with
overall effect size βj and between study variance τ
2
j , j = 1, 2. Under normal distribution assumption
for Yij and θij , the general BRMA model can be written as [19]
(
Yi1
Yi2
)
∼ N
((
θi1
θi2
)
,∆i
)
, ∆i =
(
s2i1 si1si2ρWi
si1si2ρWi s
2
i2
)
,
(
θi1
θi2
)
∼ N
((
β1
β2
)
,Ω
)
, Ω =
(
τ 2
1
τ1τ2ρB
τ1τ2ρB τ
2
2
)
, (1)
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where ∆i and Ω are the corresponding study-specific within-study and between-study covariance
matrices, and ρWi and ρB are the respective within-study and between-study correlations. When
the within-study correlations ρWi are known, inference on the overall effect sizes β1 and β2, or their
comparative measures (e.g. β1 − β2), can be based on the marginal distribution of (Yi1, Yi2)(
Yi1
Yi2
)
∼ N
((
β1
β2
)
,Vi
)
,Vi =∆i +Ω =
(
s2i1 + τ
2
1
si1si2ρwi + τ1τ2ρB
si1si2ρwi + τ1τ2ρB s
2
i2 + τ
2
2
)
.
We note that the variance of Yij is partitioned into two parts, s
2
ij and τ
2
j , and the covariance,
cov(Yi1, Yi2) = si1si2ρwi+ τ1τ2ρB, is also partitioned into two parts as the sum of within and between
study covariances.
2.2 Existing methods for PB
The commonly used graphical methods can only handle PB for univariate meta-analysis. One of the
most important graphical methods is the funnel plot [7]. The most precise estimates (typically, those
from the largest studies) are at the top of the funnel and those from less precise or smaller studies
are at the base of the funnel. The precisions of the studies are plotted against summary statistics,
whose shape should be like a funnel in the absence of PB [16]. If the studies with statistically
significant results are more likely to be published, the shape of the funnel plot may become skewed
or asymmetric.
Based on the funnel plot asymmetry, Egger (1997) [10] used a linear regression approach to detect
PB. Specifically, Egger (1997) [10] suggested to regress the effect size divided by its standard error
as dependent variable Y on the precision of the effect size P . In case of no publication bias, small
studies are expected to be close to zero on both axes (due to their high standard error), whereas
larger studies have a high precision and are thus expected to deviate from zero. In this case, the
regression line is assumed to go through the origin, so that a does not differ significantly from zero.
However, if publication bias is existent, most small studies will have relatively large effect size, and
the intercept a is thus assumed to be significantly greater than zero. In addition, each study can
5
be weighted by the inverse of the variance under a fixed or random effects assumption to control for
possible heteroscedasticity. There are several variations of the Egger’s regression test. [11] introduced
a different regression approach to detect PB, where the effect size is regressed on sample size of the
study with weights being the inverse of the variances. A similar approach was suggested by [13],
where the sample size is replaced by its inverse.
Begg and Mazumdar (1994) [9] proposed a non-parametric rank correlation method for PB based
on Kendall’s τ , which tests whether the standardized effect size and the variance of the effect size
are significantly associated. In the absence of publication bias, the variance should be independent
of the effect measure, and thus, the test statistic is assumed to be close to zero. In the presence
of publication bias, a test statistic that is significantly greater than zero indicates the presence of
publication bias. Possible variations of Begg’s rank test can be obtained by replacing standard errors
by the inverse of total sample size.
Besides Begg’s rank test, trim and fill method is another non-parametric method to detect and
correct publication bias. It is based on the idea that there are k studies present in the meta-analysis
and k0 studies missing due to publication bias, which implies an asymmetrical funnel. With respect
to trim and fill, funnel plots are applied with an effect size on the x-axis and its precision on the
y-axis. If we assume to know the true overall effect size, we will be able to estimate k0. The authors of
trim and fill proposed three estimator (i.e., R, L and G) of the number of missing studies (for details,
see [15, 16]). Using an iterative algorithm, one arrives at a random effects estimator that is used in
the preceding formula. In the absence of publication bias (i.e., k0 = 0), the approximate distributions
of three estimator are known, and can be tested for significance to decide whether publication bias
is present or not.
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3 Regression-based score test
In this section, we propose a regression-based score test for PB, which is a multivariate extension of
the Egger’s regression test. We consider a score test rather than a Wald test or a likelihood ratio test
because the score test has the advantage of being obtained by fitting the null model only and being
invariant to reparameterization. The score test can be constructed using a three-step procedure:
estimate the within-study correlation and variation; construct the regression model and likelihood;
and propose the score test.
1. The between-study variation τ 2 and between-study correlation ρB are estimated by maximizing
the restricted maximum likelihood (REML) of Model (1), denoted by τ˜ 2 and ρ˜B.
2. The bivariate regression model is constructed as
SNDi = a+ bPi + εi (2)
where SNDi =
{
Yi1 (s
2
i1 + τ
2
2
)
−1/2
, Yi2 (s
2
i2 + τ
2
2
)
−1/2
}T
,Pi =
{
(s2i1 + τ
2
1
)
−1/2
, (s2i2 + τ
2
2
)
−1/2
}T
,
and εi = {εi1, εi2}
T is standard bivariate normal random variables with covariance matrix Σi,
andΣi is a 2×2 matrix with 1 as the diagonal elements and (ρWisi1si2 + ρBτ1τ2) /
√
(s2i1 + τ
2
1
) (s2i2 + τ
2
2
)
as the off-diagonal elements.
By plugging in τ˜ 2 and ρ˜B obtained from step (I), the loglikelihood is then constructed as
logL(a, b) = −
1
2
m∑
i=1
(S˜NDi − a− bP˜i)
2, (3)
3. The score test based on model (3) is proposed, referred to as RST hereafter,
RST =
1
m
Ua
[
0, b˜(0)
]T
I0
aaUa
[
0, b˜(0)
]
, (4)
where Ua
[
0, b˜(0)
]
is the score function w.r.t a under the null, and I0
aa is sub-matrix of inverse
of the negative hessian function evaluated at (0, b˜(0)) w.r.t a.
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A detailed derivation of the score function and test statistics is provided in Appendix A of supple-
mentary materials. To be added: I am still working on the appendix
4 Simulation studies
In this section, we evaluate the performance of the proposed RST test through fully controlled
simulation studies.
4.1 Simulation studies
In our simulation studies, we compare the proposed RST test with the commonly used Egger’s
regression test, the Begg’s rank test and the Trim and Fill method. The data are generated from
BRMA as specified by model (1). To cover a wide spectrum of scenarios, we vary the values for
several factors that are considered important in practice: 1)To reflect the heterogeneity in standard
error of summary measure across studies, we sample s2ij from the square of N(0.3, 0.50) distribution,
which leads to a mean value of 0.33 for s2ij; 2) The size of the within-study variation relative to the
between-study variation may have a substantial impact on the performance of the methods. To this
end, we let the between-study variances τ 2
1
= τ 2
2
ranging from 0.5 to 1.9 to represent the random-
effects model with relatively small to large random effects. 3) For within-study and between-study
correlations, we consider ρWi being constant with value −0.5, 0 or 0.5 and ρB being constant with
−0.5, 0 or 0.5. 4) The number of studies n is set to 50, 75 and 100 to represent meta-analysis of
small to large number of studies.
We consider the Type I error setting when the selection (i.e., a study being published or not) does
not depend on the effect sizes, and power settings when the selection depends on the effect sizes. We
conduct 5000 simulations for the Type I error setting, and 1000 simulations for the power settings.
For power settings, in order to obtain n published studies, we follow the three steps: 1) N studies are
simulated, where N is an positive integer greater than n (here we choose N = 3n to ensure enough
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number of studies before selection); 2) studies are excluded based on the selection scenario; 3) finally,
n studies were randomly sampled from the studies included in the previous step. We consider missing
scenarios for completely missing and partially missing. The probability of an outcome being reported
depends on the p value of its effect size, therefore some studies may selectively report only one of the
outcomes. In addition, the selection model in the partially missing scenario is different from those
in completely missing scenarios, in that we let the logit of the probability of the jth outcome in ith
study being published be (−2.5+0.1SNDij+1.5SND
2
ij)I(SNDij < 2)+4I(SNDij ≥ 2). This selection
model is empirically estimated from a meta-analysis where the true status of a registered study being
published or not is available [20].
4.1.1 Simulation Results
Table 1 summarizes the Type I errors at the 10% nominal level of the tests under comparison. The
proposed RST test controls the Type I errors well in all settings. All univariate tests are based
on combined univariate effect measures of two outcomes. The Egger’s regression test has slightly
inflated Type I errors when the sample size is small (n = 10). We observe that the Type I errors of
the Begg’s rank test are very conservative when the sample size is relatively small but inflated when
the sample size is relatively large, which is consistent with literature in that the Begg’s rank test
does not perform well in controlling Type I errors [6]. We observe that the Trim and Fill method
controls the Type I errors well only when the between-study heterogeneity is relatively small and
is too conservative when the between-study heterogeneity is relatively large. The possible reason is
that the Trim and Fill method is very sensitive to outliers, and larger between-study heterogeneity
may introduce more outliers.
Figure 1 summarizes the power of the tests under comparison for complete missing scenario. We
display the power curve by adjusting for its critical region. Clearly, the proposed RST test is the
most powerful test under all settings considered. The Begg’s rank test and the Trim and Fill method
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are essential no power beyond the nominal level when the between-study variance is large. There are
several interesting findings from Figure 1. We observe decreasing trend for the Begg’s rank test and
the Trim and Fill method when between-study variance is increasing. This is reasonable because both
tests are nonparametric tests based on ranks, which are sensitive to outliers. Larger heterogeneity
will introduce severer problem caused by outliers.
Table 1: Type I errors (×100%) at 10% nominal level of Egger test, Begg test, Trim and Fill method
and the proposed RST test. The univariate tests based on the combined univariate measure or
Bonferroni correction are denoted as “test(C)” or “test(B)”. The number of studies n is set to 50, 75
and 100, and the between-study heterogeneity τ 2 is set to 0.5, 1.1, 1.5 and 1.9
τ
2 n Egger1 Egger1 Egger(C) Egger(B) Begg1 Begg1 Begg(C) Begg(C) TF1 TF1 TF(C) TF(B) RST
0.5 50 10.3 10.2 10.7 10.5 43 43.2 13.2 59.2 11.6 10.8 11.1 12.7 13.3
75 10.4 10.1 10.2 10.2 53.1 54 17.4 71.2 11.5 11.2 10.9 12.6 12.6
100 10.2 10.8 9.8 10 59.5 58.1 21.7 77.4 10.7 11.3 10.2 12 12.2
1.1 50 10.3 10 10.6 10.3 44.6 44.6 14 61.1 10.5 9.6 9.8 11.8 12.7
75 10.6 10.2 10 10.2 54.2 55.4 18.7 72.9 10 10 9.7 11.5 12.1
100 10.2 10.7 9.9 10.1 60.8 59.4 23 78.9 9.9 10.3 9.7 11.4 11.4
1.5 50 10.2 10.1 10.5 10.3 44.9 45.1 14.2 61.6 9.8 9.2 9.3 11.3 12.6
75 10.5 10.3 9.9 10.2 54.6 55.7 19.1 73.4 9.4 9.6 9.3 10.9 11.9
100 10.3 10.7 9.9 10 61.1 59.6 23.3 79.2 9.5 9.6 9.5 11 11.4
1.9 50 10.2 10.1 10.6 10.2 45.2 45.3 14.3 61.9 9.4 8.8 8.9 10.9 12.4
75 10.5 10.3 9.9 10.3 54.8 56 19.2 73.6 9.1 8.9 8.9 10.4 11.8
100 10.3 10.7 10 10.1 61.3 59.8 23.5 79.4 9.1 9.2 9.2 10.7 11.3
5 Data analysis
In this section, we consider two case studies: 1) lymph node metastasis in women with cervical
cancer; 2) efficacy and safety of drug-eluting stens and bare-metal stens. The first analysis illustrates
the situation when the existing univariate tests can be applied to a combined outcome, but the
combination procedure of two outcomes will hamper the testing power. The second analysis illustrate
the situation when two outcome cannot be combined hence the existing univariate tests can be only
10
02
 
5

75
E     
  	 
  
Egger(C)
Egger(B)
B    
    
Begg(C)
Begg(B)
T  
  
TF(C)
TF(B)
RST
I
ff
fi
fl
ffi

75
1
 
!
" # $ % & '
( ) * + , -
Egger(C)
Egger(B)
. / 3 4 6
7 8 9 : ;
Begg(C)
Begg(B)
< = >
? @ A
TF(C)
TF(B)
RST
II
C
D
F
G
H
75
I
J
K
L M N O P Q
R S U V W X
Egger(C)
Egger(B)
Y Z [ \ ]
^ _ ` a b
Begg(C)
Begg(B)
c d e
f g h
TF(C)
TF(B)
RST
III
i
j
k
l
m
75
n o p q r s
t u v w x y
Egger(C)
Egger(B)
z { | } ~
    
Begg(C)
Begg(B)
  
  
TF(C)
TF(B)
RST
IV
Ł




75



     
     
Egger(C)
Egger(B)
    ¡ ¢
£ ¤ ¥ ¦ §
Begg(C)
Begg(B)
¨ © ª
« ¬ ­
TF(C)
TF(B)
RST
V
®
¯
°
±
²
75
³
´
µ
¶ · ¸ ¹ º »
¼ ½ ¾ ¿ À Á
Egger(C)
Egger(B)
Â Ã Ä Å Æ
Ç È É Ê Ë
Begg(C)
Begg(B)
Ì Í Î
Ï Ð Ñ
TF(C)
TF(B)
RST
VI
Ò
Ó
Ô
Õ
Ö
75
× Ø Ù Ú Û Ü
Ý Þ ß à á â
Egger(C)
Egger(B)
ã ä å æ ç
è é ê ë ì
Begg(C)
Begg(B)
í î ï
ð ñ ò
TF(C)
TF(B)
RST
VII
ó
ô
õ
ö
÷
75
ø
ù
ú
û ü ý þ ß E
      
Egger(C)
Egger(B)
B    	

    
Begg(C)
Begg(B)
T  
  
TF(C)
TF(B)
RST
VIII
0
2

5

75
1


   ff fi fl
ffi   ! " #
Egger(C)
Egger(B)
$ % & ' (
) * + , -
Begg(C)
Begg(B)
. / 3
4 6 7
TF(C)
TF(B)
RST
IX
8
9
:
;
<
60 80
Egger1
Egger2
Egger(C)
Egger(B)
Begg1
Begg2
Begg(C)
Begg(B)
TF1
TF2
TF(C)
TF(B)
RST
X
0 25 50 75
Egger1
Egger2
Egger(C)
Egger(B)
Begg1
Begg2
Begg(C)
Begg(B)
TF1
TF2
TF(C)
TF(B)
RST
XI
0 25 50 75
100
Egger1
Egger2
Egger(C)
Egger(B)
Begg1
Begg2
Begg(C)
Begg(B)
TF1
TF2
TF(C)
TF(B)
RST
XII
F
igu
re
1:
P
ow
er
p
lot.
(w
ill
ch
an
ge
th
e
p
an
el
title
later)
ap
p
lied
sep
arately
to
th
e
ou
tcom
es.
U
n
d
er
b
oth
situ
ation
s,
th
e
p
rop
osed
score
test
sh
ow
s
sign
ifi
can
t
p
ow
er
gain
over
th
e
ex
istin
g
u
n
ivariate
tests.
11
5.1 Diagnosis of lymph node metastasis in women with cervical cancer
We compare the performance of the proposed test with existing univariate tests by detecting the pub-
lication bias of the data in [21]. Scheidler et al. compared three imaging techniques for the diagnosis
of lymph node metastasis in women with cervical cancer. Forty-four studies in total were included:
17 studies evaluated lymphangiography, another 17 studies examined computed tomography and
the remaining 10 studies focused on magnetic resonance imaging. Diagnosis of metastatic disease
by lymphangiography (LAG) is based on the presence of nodal-filling defects, whereas computed
tomography (CT) and magnetic resonance imaging (MRI) rely on nodal enlargement.
The results of the statistical tests are shown in the upper panel of Table 2. The proposed RST
test provides significant results by jointly estimating publication bias for sensitivities and specificities.
Both the Egger test and Begg rank test detect significant publication bias for specificity. While severe
asymmetry has been observed for specificities, the Trim and Fill method does not detect publication
bias for neither sensitivity nor specificity. A possible reason for this result is that the Trim and
Fill method is very sensitive to outliers. Using the diagnostic odds ratio as a combined measure to
detect publication bias may lead to loss of power, and non of the three univariate methods identify
significant publication bias based on logDOR.
5.2 Efficacy and safety of drug-eluting stents vs. bare-metal stents in
acute myocardial infarction
Primary percutaneous coronary intervention (PCI) is a preferred reperfusion strategy for patients
presenting with acute myocardial infarction. Routine implantation of bare-metal stents has been
associated with improved clinical outcome mainly because of the decreased risk for reintervention.
Restenosis is an important limitation of the use of bare-metal stents in patients with acute myocardial
infarction. Drug-eluting stents effectively reduce restenosis while maintaining a good safety profile
in many lesion and patients groups. However, concerns have been raised with regard to the safety of
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Table 2: P values of testing publication bias using the Egger test, the Begg test, the Trim and Fill
method (TF) and the proposed omnibus score test (RST).
Test Outcome 1 Outcome 2 Combined univariate measure
Case study 1 Egger 0.642 < 0.001 0.091
Begg 0.761 0.002 0.511
TF 0.125 0.250 0.500
MPBT < 0.001
Case study 2 Egger 0.933 0.619 –
Begg 1.00 0.720 –
TF 0.500 0.500 –
MPBT 0.006
∗ jointly test for publication bias of Outcome 1 and Outcome 2
drug-eluting stents in patients with acute myocardial infarction. Implantation of drug-eluting stents
during primary PCI could be associated with an increased risk for stent thrombosis. Recent studies
reported results of drug-eluting stents in patients undergoing primary PCI for acute myocardial
infarction. However, the power of these studies were insufficient to assess the rare adverse events,
and the results were not consistent. [22] performed a meta-analysis based on individual patient data
from randomized trials comparing drug-eluting stents with bare-metal stents to evaluate the efficacy
and safety of drug-eluting stents. Eight randomized trials comparing drug-eluting stents with bare-
metal stents in 2786 patients with acute myocardial infarction were included in the meta-analysis.
[22] concluded that the use of drug-eluting stents in patients with acute myocardial infarction was
safe and improved clinical outcomes by reducing the risk of reintervention compared with bare-metal
stents.
We estimate the publication bias of the primary efficacy outcome and primary safety outcome
using the Egger test, the Begg test, the Trim and Fill method and the proposed MPBT test. It
is worth mentioning that unlike the meta-analysis of diagnostic accuracy study where a combined
univariate measure (i.e., logDOR) can be used for the existing univariate tests, for the meta-analysis
of drug efficacy and safety study, it is hard to interpret its clinical meaning when combine the efficacy
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outcome and primary safety outcome together. Therefore, we apply the existing univariate tests on
the efficacy outcome and safety outcome separately. On the other hand, the proposed MPBT has no
such limitation and can test for publication bias for the two outcomes jointly.
The results of the statistical tests are shown in the lower panel of Table2. The proposed MPBT
test provides a significant result by jointly estimating publication bias for the efficacy and the safety
outcomes. Both the Egger test and Begg rank test detect significant publication bias for specificity.
While severe asymmetry has been observed for specificities, the Trim and Fill method does not detect
publication bias for neither sensitivity nor specificity.
6 Discussion
We have proposed an omnibus score test for detecting publication bias in multivariate random-
effects meta-analysis for both completely unpublished scenario and selectively report part of multiple
outcome scenario, which is a natural multivariate extension of the multivariate regression model.
This approach has a variety of advantages.
In the proposed test the joint modeling on multiple outcomes uses more information and limits
some of the challenges present in standard tests for publication bias. For example for insufficient
number of studies (less than 10) there is not enough power for standard tests to distinguish chance
from real asymmetry. The multivariate nature of the proposed test on the other hand, allows us to
use correlated outcomes and thereby borrow information across outcomes and increase power. The
proposed test also allows for jointly testing for multiple outcomes with different types and scales (as
illustrated in the case studies) by borrowing information across outcomes.
Another problem that this test addresses is the selective reporting/publishing of only significant
results by investigators who may measure different types of outcomes or just a single outcome. These
cases correspond to partially and completely missing scenarios respectively. The proposed test detects
PB for both scenarios simultaneously. Specifically, in the simulation study the proposed test yielded
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results with better statistical properties, controlled for type I errors well and was shown to be more
powerful than existing tests.
One limitation of the proposed test is it requires within-study correlations to be known, which
are often not available. Nonetheless, within-study correlations can be obtained, from potentially
available individual patient data (IPD) by a proportion of studies, using bootstrapping methods. In
the case where the IPD are not available, extensions of the proposed test can be constructed using
alternative synthesis models that do not require within-study correlations(such as Riley’s method).
Bayesian extension of the proposed model can also be considered placing a prior distribution upon
unknown within-study correlations. The extension of the proposed test using estimated within-study
correlations is a topic of future work.
To summarize, we have developed a useful test to detect publication bias in multivariate random-
effects meta-analysis. By well designed simulation studies, we found the proposed test is substantially
more powerful than the existing tests by borrowing information across outcomes. Thus, this test can
be a useful addition to tackle the publication bias problem in comparative effectiveness research.
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